Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase
Abstract Breast cancer is a prevalent malignant tumor among women with an increasing incidence rate annually. Breast cancer stem cells (BCSCs) are integral in impeding tumor advancement and addressing drug resistance. Bestatin serves as an adjuvant chemotherapy, triggering apoptosis in cancer cells....
Sparad:
| Huvudupphov: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Springer
2024-05-01
|
| Serie: | Discover Oncology |
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/s12672-024-01063-4 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|